Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Pregnant Women

Active, not recruitingOBSERVATIONAL

Enrollment

2,700

Participants

Timeline

Start Date

December 12, 2024

Primary Completion Date

April 11, 2025

Study Completion Date

October 31, 2025

Conditions

Pertussis VaccinesPertussis (Whooping Cough)

Trial Locations (1)

Faculty of Medicine Siriraj Hospital Mahidol University, Bangkok

All Listed Sponsors

lead

BioNet-Asia Co., Ltd.

INDUSTRY

NCT06888076 - Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Pregnant Women | Biotech Hunter | Biotech Hunter